Skeletal Dysplasia

2

Review clinical trials related to Skeletal Dysplasia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Data Collection of Patients With Rare Bone Diseases

RD-DATA is a retrospective and prospective data collection, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different sources and evaluating several aspects of the diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Luca SangiorgiUpdated: Nov 20, 2025Locations: 1
Eligibility criteria

All patients affected by rare diseases with predominantly skeletal involvement

Any condition unrelated to rare diseases with predominantly skeletal involvement

Status: Recruiting

Decoding the Genetic Landscape of Skeletal Diseases

This 5-year project aims to (1) search for genetic causes for yet unsolved congenital skeletal disorders (GSDs); (2) study consequences of the newly identified pathogenic variants in cells and in transgenic mice, (3) summarize data on natural course and complications for different GSD groups. For patients with unsolved GSD, the investigators search for molecular causes of GSDs using whole genome sequencing (WGS) and total ribonucleic acid (RNA) sequencing. Candidate gene variants are selected using genome or transcriptome sequencing data, clinical findings and screening of omics databases. Causality of the new variants is studied in cells and in transgenic mice models. Molecular and clinical findings are summarized for different GSD groups.

Participants needed: 450
Trial details
Biological sex: AllType: ObservationalSponsor: Karolinska InstitutetUpdated: May 25, 2023Locations: 1
Eligibility criteria

Not listed